Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 2109 records

$769,398.00

Oct 1, 2011
Description:

Transcriptional regulators of the 5-HT1A receptor gene

Organization: Canadian Institutes of Health Research
Location: Ottawa, Ontario, CA K1N 6N5

$286,733.00

Oct 1, 2011
Description:

Involvement of PDB3 and PDB4-related genes in bone diseases

Organization: Canadian Institutes of Health Research
Location: Québec, Quebec, CA G1K 7P4

$717,121.00

Oct 1, 2011
Description:

Activation, Expression and Hormonal Regulation of the Human Pituitary Growth Hormone Gene

Organization: Canadian Institutes of Health Research
Location: Winnipeg, Manitoba, CA R3T 2N2

$159,196.00

Oct 1, 2011
Description:

Development of ganglioside-based therapies for Huntington's disease

Organization: Canadian Institutes of Health Research
Location: Edmonton, Alberta, CA T6G 2E1

$794,178.00

Oct 1, 2011
Description:

Adding Motivational Interviewing to Cognitive Behavioural Therapy for Severe Generalized Anxiety Disorder

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M3J 1P3

$749,900.00

Oct 1, 2011
Description:

Molecular Regulation of E2F-1 Dependent Gene Transcription and Cell Death Signaling Pathways in Ventricular Myocytes

Organization: Canadian Institutes of Health Research
Location: Winnipeg, Manitoba, CA R3T 2N2

$76,244.00

Oct 1, 2011
Description:

Reassessment of anti-platelet therapy using individualized strategies - Association of genetic variants to adverse outcomes in clopidogrel treated patients after percutaneous coronary intervention: the RAPID AGAP study

Organization: Canadian Institutes of Health Research
Location: Ottawa, Ontario, CA K1Y 4W7

$812,446.00

Oct 1, 2011
Description:

Roles of carcinoma associated fibroblasts and tumor stromal genes in lung cancer

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 2C4

$747,275.00

Oct 1, 2011
Description:

Glucose regulation of insulin secretion and metabolic enzymes' gene expression

Organization: Canadian Institutes of Health Research
Location: Montréal, Quebec, CA H2X 0A9

$1,473,232.00

Oct 1, 2011
Description:

Mutational and Functional Analysis of Genes Identified by GWAS Studies of Alzheimer's Disease

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5S 1A1